Loading organizations...
§ Private Profile · Pittsburgh, PA, USA
Medical device company developing absorbable surgical adhesives and sealants for plastic and reconstructive surgery wound management.
Cohera Medical is a Raleigh, North Carolina-based medical device company that develops absorbable surgical adhesives and sealants for internal wound management. The organization's lead commercial product, TissuGlu Surgical Adhesive, is a sprayable bonding agent utilized in large flap procedures such as abdominoplasties and mastectomies to significantly reduce fluid accumulation and eliminate the need for post-surgical drains. To support its clinical trials and ongoing commercialization efforts, the enterprise has raised over $75 million in capital across four private funding rounds, including a $17 million Series D financing in 2013. Following regulatory approval, the company initiated a United States beta launch and supplied hospitals in Germany, completing an extensive clinical study involving over 200 cases managed by executives like Dottie Clower and William M. Cotter. Cohera Medical was originally founded in 2003 by Eric J. Beckman and Patrick Daly.
Cohera Medical has raised $101.3M across 4 funding rounds.
Cohera Medical has raised $101.3M in total across 4 funding rounds.
Cohera Medical has raised $101.3M across 4 funding rounds. Most recently, it raised $50.0M Other Equity in October 2015.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 22, 2015 | $50M Venture Round | ALI Satvat | — | Announced |
| Jan 23, 2014 | $9.3M Series D Plus | — | — | Announced |
| Feb 15, 2013 | $17M Series D | JAY Kern | — | Announced |
| Dec 19, 2011 | $25M Series C | — | Kern Capital | Announced |
Cohera Medical has raised $101.3M in total across 4 funding rounds.
Cohera Medical's investors include Ali Satvat, Jay Kern, Kern Capital.